Role of particle size in phagocytosis of polymeric microspheres
- PMID: 18373181
- PMCID: PMC2793372
- DOI: 10.1007/s11095-008-9562-y
Role of particle size in phagocytosis of polymeric microspheres
Abstract
Purpose: Polymeric microspheres are extensively researched for applications in drug and vaccine delivery. However, upon administration into the body, microspheres are primarily cleared via phagocytosis by macrophages. Although numerous studies have reported on the biochemical pathways of phagocytosis, relatively little is known about the dependence of phagocytosis on particle size. Here, we investigate the previously unexplained dependence of phagocytosis on particle size.
Methods: Rat alveolar macrophages and IgG-opsonized and non-opsonized polystyrene microspheres were used as model macrophages and drug delivery particles. Phagocytosis, attachment and internalization were measured by flow cytometry and time-lapse video microscopy.
Results: Particles possessing diameters of 2-3 microm exhibited maximal phagocytosis and attachment. Rate of internalization, however, was not affected significantly by particle size. Maximal attachment of 2-3 microm microspheres is hypothesized to originate from the characteristic features of membrane ruffles in macrophages. Elimination of ruffles via osmotic swelling nearly eliminated the peculiar size-dependence of phagocytosis. A simple mathematical model is presented to describe the dependence of phagocytosis on particle size.
Conclusions: The dependence of phagocytosis on particle size originated primarily from the attachment step. These results reveal the importance of controlling drug delivery particle size distribution and selecting the size appropriate for avoiding or encouraging phagocytosis.
Figures





Similar articles
-
Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages.J Control Release. 2007 May 14;119(1):69-76. doi: 10.1016/j.jconrel.2007.01.013. Epub 2007 Feb 1. J Control Release. 2007. PMID: 17335927
-
Phagocytic activity of alveolar macrophages toward polystyrene latex microspheres and PLGA microspheres loaded with anti-tuberculosis agent.Colloids Surf B Biointerfaces. 2007 Nov 15;60(2):221-8. doi: 10.1016/j.colsurfb.2007.06.017. Epub 2007 Jun 21. Colloids Surf B Biointerfaces. 2007. PMID: 17683920
-
Flow cytometric and optical microscopic evaluation of poly(D, L-lactide-co-glycolide) microspheres phagocytosis by pig alveolar macrophages.J Control Release. 1999 Apr 19;58(3):289-301. doi: 10.1016/s0168-3659(98)00166-7. J Control Release. 1999. PMID: 10099154
-
Phagocytosis of monosize polystyrene-based microspheres having different size and surface properties.J Biomater Sci Polym Ed. 1995;7(4):329-42. doi: 10.1163/156856295x00355. J Biomater Sci Polym Ed. 1995. PMID: 7495763
-
Pulmonary and thoracic macrophage subpopulations and clearance of particles from the lung.Environ Health Perspect. 1992 Jul;97:17-46. doi: 10.1289/ehp.929717. Environ Health Perspect. 1992. PMID: 1396454 Free PMC article. Review.
Cited by
-
The contribution of neutrophils to bacteriophage clearance and pharmacokinetics in vivo.JCI Insight. 2024 Oct 22;9(20):e181309. doi: 10.1172/jci.insight.181309. JCI Insight. 2024. PMID: 39435664 Free PMC article.
-
Distribution and Cellular Uptake of PEGylated Polymeric Particles in the Lung Towards Cell-Specific Targeted Delivery.Pharm Res. 2015 Oct;32(10):3248-60. doi: 10.1007/s11095-015-1701-7. Epub 2015 May 23. Pharm Res. 2015. PMID: 26002743 Free PMC article.
-
Formulation and evaluation of drug-loaded targeted magnetic microspheres for cancer therapy.Int J Nanomedicine. 2013;8:1393-402. doi: 10.2147/IJN.S43479. Epub 2013 Apr 10. Int J Nanomedicine. 2013. PMID: 23630421 Free PMC article.
-
Micro and nanoparticle drug delivery systems for preventing allotransplant rejection.Clin Immunol. 2015 Sep;160(1):24-35. doi: 10.1016/j.clim.2015.04.013. Epub 2015 May 1. Clin Immunol. 2015. PMID: 25937032 Free PMC article. Review.
-
Modeling, design, and machine learning-based framework for optimal injectability of microparticle-based drug formulations.Sci Adv. 2020 Jul 8;6(28):eabb6594. doi: 10.1126/sciadv.abb6594. eCollection 2020 Jul. Sci Adv. 2020. PMID: 32923598 Free PMC article.
References
-
- LaVan DA, Lynn DM, Langer R. Moving smaller in drug discovery and delivery. Nat Rev Drug Discov. 2002;1:77–84. - PubMed
-
- Hanes J, Chiba M, Langer R. Polymer microspheres for vaccine delivery. Pharm Biotechnol. 1995;6:389–412. - PubMed
-
- Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Control Release. 2003;90:261–280. - PubMed
-
- Song CX, Labhasetwar V, Cui XM, Underwood T, Levy RJ. Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: Results with an acute dog model. J Control Release. 1998;54:201–211. - PubMed
-
- Sakagami M, Byron PR. Respirable microspheres for inhalation: The potential of manipulating pulmonary disposition for improved therapeutic efficacy. Clin Pharmacokinet. 2005;44:263–277. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources